Publications
- Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia patients - worldwide battlefield2015 | Faculty of Medicine in Pilsen
- Discontinuation of biological therapy with tyrosine kinase inhibitors in chronic myeloid leukemia patients2014 | Faculty of Medicine in Pilsen
- Successful peripheral blood stem cells collection in a patient with nilotinib treated chronic myeloid leukemia. patient2010 | Central Library of Charles University
- Successful peripheral blood stem cells collection in imatinib pretreated and nilotinib-treated chronic myeloid leukemia patient2010 | Faculty of Medicine in Pilsen
- Successful peripheral blood stem cells collection in a patient with nilotinib treated chronic myeloid leukemia. patient2010 | Faculty of Medicine in Pilsen
- Successful peripheral blood stem cells collection in imatinib pretreated and nilotinib-treated chronic myeloid leukemia patientPublication without faculty affiliation
- Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)2023 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group2023 | Faculty of Medicine in Pilsen, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Managing BTK inhibitor treatment-related adverse events in patients with chronic lymphocytic leukaemia - cardiovascular complications and bleeding2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...